Lymphoma, Large B-Cell, Diffuse
Showing 9976 - 10000 of >10,000
Healthy Trial in Berlin (Tralokinumab administered as 1 × X mL with Device A, Tralokinumab administered as 2 × Y mL with Device
Completed
- Healthy
- Tralokinumab administered as 1 × X mL with Device A
- Tralokinumab administered as 2 × Y mL with Device B
-
Berlin, GermanyLEO Pharma Investigational Site
Jan 4, 2022
Myocardial Infarction, Anemia Trial in Worldwide (Red Blood Cell Transfusion)
Recruiting
- Myocardial Infarction
- Anemia
- Red Blood Cell Transfusion
-
Little Rock, Arkansas
- +131 more
May 3, 2022
Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial in Wuhan (CAR-T (CAR-GPRC5D))
Recruiting
- Relapsed/Refractory Multiple Myeloma
- Plasma Cell Leukemia
- CAR-T (CAR-GPRC5D)
-
Wuhan, Hu Bei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
May 17, 2022
Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD Trial run by the National Heart, Lung, and Blood
Not yet recruiting
- Immune Mediated Anemia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)
Not yet recruiting
- Lymphoma
- +2 more
- Web Application
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 4, 2022
Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Bortezomib)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
-
Clayton, Victoria, Australia
- +14 more
Aug 14, 2020
Gout, Chronic Kidney Diseases Trial in Southend on Sea (Anakinra 100mg and Placebo Depo-Medrone, Depo-Medrone 120mg and Placebo
Completed
- Gout
- Chronic Kidney Diseases
- Anakinra 100mg and Placebo Depo-Medrone
- Depo-Medrone 120mg and Placebo (Anakinra)
-
Southend on Sea, Essex, United KingdomSouthend Hospital
Apr 5, 2022
Extensive Stage Small Cell Lung Cancer Trial in Shanghai (recombinant anti-PD-L1 mAb injection combined with carboplatin and
Recruiting
- Extensive Stage Small Cell Lung Cancer
- recombinant anti-PD-L1 monoclonal antibody injection combined with carboplatin and etoposide
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
May 9, 2022
Myeloma Trial in Rochester (Hyperbaric oxygen)
Recruiting
- Myeloma
- Hyperbaric oxygen
-
Rochester, New YorkJames P. Wilmot Cancer Center at University of Rochester Medical
May 5, 2022
Celiac Disease Trial in Boston (Gluten powder 4g)
Completed
- Celiac Disease
- Gluten powder 4g
-
Boston, Massachusetts
- +1 more
May 5, 2022
Multiple Myeloma Trial in Tampa (biological, procedure, drug)
Active, not recruiting
- Multiple Myeloma
- Survivin Vaccine
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 7, 2022
Cognitive Decline, Blood Pressure, Hypertension Trial in Dallas (Clinical Support Decision Tool)
Recruiting
- Cognitive Decline
- +2 more
- Clinical Support Decision Tool
-
Dallas, TexasUT Southwestern Medical Center
Aug 29, 2022
MDS, Chronic Myelocytic Leukemia, Acute Myeloid Leukemia Trial in United States (Azacitidine, ASTX030 (cedazuridine +
Recruiting
- Myelodysplastic Syndromes
- +3 more
- Azacitidine
- +2 more
-
Hackensack, New Jersey
- +6 more
Nov 18, 2022
Diabetes Trial in Nashville (Diabetes Care Gaps Patient Portal Intervention)
Recruiting
- Diabetes Mellitus
- Diabetes Care Gaps Patient Portal Intervention
-
Nashville, TennesseeVanderbilt University Medical Center
May 1, 2022
Different Risk Factors on Growth Parameters of Thalassemic
Not yet recruiting
- Thalassemia Major
- serum ferritin and AST
- (no location specified)
Mar 29, 2022
Ovarian Cancer Trial in Villejuif (Pembrolizumab, Bevacizumab, pegylated liposomal doxorubicin (PLD))
Active, not recruiting
- Ovarian Cancer
- Pembrolizumab
- +2 more
-
Villejuif, Val De Marne, FranceGustave Roussy
Jul 21, 2021
Head and Neck Tumors Trial in France (Atezolizumab, Bevacizumab)
Active, not recruiting
- Head and Neck Neoplasms
-
Lyon, France
- +6 more
May 16, 2022
Frailty Syndrome Trial in Erlangen (WB-EMS, social contact control group)
Completed
- Frailty Syndrome
- WB-EMS
- social contact control group
-
Erlangen, Bavaria, GermanyInstitute of Medical Physics, University of Erlangen-Nürnberg
Jul 18, 2022
Dengue Trial in Lausanne (LD vehicle-GNP, LD PepGNP-Dengue, HD vehicle-GNP)
Completed
- Dengue
- LD vehicle-GNP
- +3 more
-
Lausanne, Vaud, SwitzerlandCenter for Primary Care and Public Health, (Unisante)
Nov 28, 2022
Healthy Participants Trial in Moldova, Republic of, Romania, United States (REGN10933 + REGN10987, Placebo)
Completed
- Healthy Participants
- REGN10933 + REGN10987
- Placebo
-
Mesa, Arizona
- +133 more
Oct 6, 2021
Whiplash, Temporomandibular Joint Pain, Dry Needling Technique Trial in Madrid (Dry needling)
Not yet recruiting
- Whiplash
- +2 more
- Dry needling
-
Madrid, SpainPatricia Recio Ramos
Aug 28, 2023
Serologically Active Adult Systemic Lupus Erythematosus Trial in Nantes, Paris (Autologous EBV specific CTL infusion)
Terminated
- Serologically Active Adult Systemic Lupus Erythematosus
- Autologous EBV specific CTL infusion
-
Nantes, France
- +2 more
Mar 24, 2022
Endometriosis Related Pain, Overactive Bladder, Diabetic Neuropathic Pain Trial in Groningen (BAY1817080, [14C]BAY1817080)
Completed
- Endometriosis Related Pain
- +3 more
-
Groningen, NetherlandsPRAHealthSciences
May 19, 2022